Your own comments from two months ago (#msg-25081126):
“The beta interferons used to treat MS all lead to antibodies with the time-to-antibodies being directly related to the dosing strength… eventually the antibodies neutralize the interferons and these patients become a natural to switch to Copaxone.”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”